Abstract:In this work, twinned anhydrous guanine β microplatelets were synthesized for the first time in the presence of a polyvinylpyrrolidone. The twinning angle of the two c axes for the synthetic and biogenic twinned guanine crystals is 84°, very similar to each other.
“…More interestingly, the angles between the two c axes were measured to take some specific angles, that is, approximately 45°, 63°, and 85° (Figure 3 e, j; see Figure S8 for the 63° case). These observations lead us to conclude that the as‐obtained cross‐shaped guanine crystals, SGmPs‐β (I) and SGmPs‐β (X), are twinned crystals with the (100) plane as the twinning plane, similar to our previous report [37] …”
Section: Methodssupporting
confidence: 89%
“…This is achieved through a phase transformation of a hydrated amorphous guanine phase in an organic solvent, such as dimethyl sulfoxide, with the presence of polyvinylpyrrolidone (PVP) [36] . By using a mixed solvent of formamide and water with poly(1‐vinylpyrrolidone‐co‐vinyl acetate) (P(VP‐co‐VA)) as additive, twinned microplatelets with morphologies such as cross and square shapes can be obtained [37] . However, the synthesis of β‐AG microplatelets with (100) exposed plane with similar morphological and crystallographic control as in biological ones is still yet to be demonstrated.…”
Section: Methodsmentioning
confidence: 99%
“…An umber of previouss tudies aimed to achieve similarc ontrol of the polymorph and morphology of guanine crystalssyntheticallyi nt he last years. [34][35][36][37][38] Utilizing chitosans ubstrates in the presence of poly(l-glutamic acid), Oaki et al synthesized a thin layer of aggregates of platy AG crystals,w hile it is unclear whether the synthesized AG is a or b phased ue to the low quality of X-ray diffraction patterns. [35] Gur et al demonstrated the polymorph controlb etween GM and AG by controlling the pH in the aqueous environment.…”
mentioning
confidence: 99%
“…Similar SGmPs were obtained by replacing P(VP-co-VA) with another polymera dditive poly(1vinylpyrrolidone) (PVP) for aw ider ange of concentrations as well (0.01-10 mg mL À1 )( Figure S5). Due to the hydrophobic nature of the vinylpyrrolidone (VP)g roup, we hypothesize that P(VP-co-VA) and PVP may preferentially absorb onto the more hydrophobic (100) plane insteado fo ther planeso fA G, [36][37] which contributest ot he formation of the guaninem icroplatelets with (100) exposing planes.…”
mentioning
confidence: 99%
“…These observations lead us to conclude that the as-obtained cross-shaped guanine crystals,S GmPs-b (I) and SGmPs-b (X), are twinned crystals with the (100) plane as the twinning plane, similar to our previousreport. [37] Lastly,w hen guanosine (GR) or adenine( A) was used during the synthesis, a phase SGmPs were obtained (Figure 4). Similar to otherc ases, the SGmPs synthesized with the presenceo fA and GR, despite the structurald ifferences, exhibit (100) exposing planesa ccording to the PXRD and SAED measurements (Figure 4a,f ,e ,j ).…”
b-Phase anhydrous guanine (b-AG) crystalsa re one of the most widespreado rganic crystals to construct optical structures in organisms. Currently,n os ynthetic method is available that allows for producing guanine crystals with similarc ontrol in size, morphology,a nd crystallographya si nb iological ones. Herein, af acile one-step synthesis route to fabricateb io-inspired guaninem icroplatelets with (100) exposing planesi na lmost pure b-phase is reported. Thes ynthesis is based on ap recipitation process of ag uanine sodium hydroxide solution in formamide with poly(1-vinylpyrrolidone-co-vinyl acetate) as a morphologicala dditive. Due to their uniform size (ca. 20 mm) and thickness (ca. 110nm), the crystals represent the first synthetic guanine microplatelets that exhibit strong structuralc olorationa nd pearlescent lusters. Moreover,t his synthesis route was utilized as am odel system to investigate the effects of guanine analogues, including uric acid, hypoxanthine, xanthine,a denine,a nd guanosine, during the crystallization process. Our results indicate that the introduction of guanine analogues not only can reduce the required synthesis temperature but also provide av ersatile control in crystal morphologya nd polymorph selection between the a-phase AG (a-AG)a nd bAG. Turbiditye xperiments showt hat the bAG microplatelets are formed with af ast precipitation rate in comparison to a-AG, suggesting that the formation of bAG crystals follows ak inetically driven process.
“…More interestingly, the angles between the two c axes were measured to take some specific angles, that is, approximately 45°, 63°, and 85° (Figure 3 e, j; see Figure S8 for the 63° case). These observations lead us to conclude that the as‐obtained cross‐shaped guanine crystals, SGmPs‐β (I) and SGmPs‐β (X), are twinned crystals with the (100) plane as the twinning plane, similar to our previous report [37] …”
Section: Methodssupporting
confidence: 89%
“…This is achieved through a phase transformation of a hydrated amorphous guanine phase in an organic solvent, such as dimethyl sulfoxide, with the presence of polyvinylpyrrolidone (PVP) [36] . By using a mixed solvent of formamide and water with poly(1‐vinylpyrrolidone‐co‐vinyl acetate) (P(VP‐co‐VA)) as additive, twinned microplatelets with morphologies such as cross and square shapes can be obtained [37] . However, the synthesis of β‐AG microplatelets with (100) exposed plane with similar morphological and crystallographic control as in biological ones is still yet to be demonstrated.…”
Section: Methodsmentioning
confidence: 99%
“…An umber of previouss tudies aimed to achieve similarc ontrol of the polymorph and morphology of guanine crystalssyntheticallyi nt he last years. [34][35][36][37][38] Utilizing chitosans ubstrates in the presence of poly(l-glutamic acid), Oaki et al synthesized a thin layer of aggregates of platy AG crystals,w hile it is unclear whether the synthesized AG is a or b phased ue to the low quality of X-ray diffraction patterns. [35] Gur et al demonstrated the polymorph controlb etween GM and AG by controlling the pH in the aqueous environment.…”
mentioning
confidence: 99%
“…Similar SGmPs were obtained by replacing P(VP-co-VA) with another polymera dditive poly(1vinylpyrrolidone) (PVP) for aw ider ange of concentrations as well (0.01-10 mg mL À1 )( Figure S5). Due to the hydrophobic nature of the vinylpyrrolidone (VP)g roup, we hypothesize that P(VP-co-VA) and PVP may preferentially absorb onto the more hydrophobic (100) plane insteado fo ther planeso fA G, [36][37] which contributest ot he formation of the guaninem icroplatelets with (100) exposing planes.…”
mentioning
confidence: 99%
“…These observations lead us to conclude that the as-obtained cross-shaped guanine crystals,S GmPs-b (I) and SGmPs-b (X), are twinned crystals with the (100) plane as the twinning plane, similar to our previousreport. [37] Lastly,w hen guanosine (GR) or adenine( A) was used during the synthesis, a phase SGmPs were obtained (Figure 4). Similar to otherc ases, the SGmPs synthesized with the presenceo fA and GR, despite the structurald ifferences, exhibit (100) exposing planesa ccording to the PXRD and SAED measurements (Figure 4a,f ,e ,j ).…”
b-Phase anhydrous guanine (b-AG) crystalsa re one of the most widespreado rganic crystals to construct optical structures in organisms. Currently,n os ynthetic method is available that allows for producing guanine crystals with similarc ontrol in size, morphology,a nd crystallographya si nb iological ones. Herein, af acile one-step synthesis route to fabricateb io-inspired guaninem icroplatelets with (100) exposing planesi na lmost pure b-phase is reported. Thes ynthesis is based on ap recipitation process of ag uanine sodium hydroxide solution in formamide with poly(1-vinylpyrrolidone-co-vinyl acetate) as a morphologicala dditive. Due to their uniform size (ca. 20 mm) and thickness (ca. 110nm), the crystals represent the first synthetic guanine microplatelets that exhibit strong structuralc olorationa nd pearlescent lusters. Moreover,t his synthesis route was utilized as am odel system to investigate the effects of guanine analogues, including uric acid, hypoxanthine, xanthine,a denine,a nd guanosine, during the crystallization process. Our results indicate that the introduction of guanine analogues not only can reduce the required synthesis temperature but also provide av ersatile control in crystal morphologya nd polymorph selection between the a-phase AG (a-AG)a nd bAG. Turbiditye xperiments showt hat the bAG microplatelets are formed with af ast precipitation rate in comparison to a-AG, suggesting that the formation of bAG crystals follows ak inetically driven process.
Biomimetic synthesis of guanine crystals has been focused on in the last years. However, multi-functional guanine crystals occluded with fluorescent molecules have not been realized in the laboratory. Here, the controllable synthesis of guanine crystal microplatelets with fluorescence and pearlescence was achieved for the first time by incorporating Nile red (NR) or fluorescein isothiocyanate (FITC) molecules into guanine crystals. The synthesized fluorescent guanine crystals are pure β-phase anhydrous guanine single crystals. Aqueous suspensions with NR-and FITC-doped guanine crystals exhibit distinct pearlescence. The fluorescence intensities of NR and FITC were greatly enhanced after being doped into guanine crystals due to the inhibition of aggregation-caused quenching. Moreover, films composed of fluorescent guanine microplatelets exhibit high diffuse reflection intensity (70 %). This work provides a strategy to synthesize multifunctional materials composed of organic crystals occluded with dyes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.